chr5-45695884-G-GCCGCCGCCA
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_021072.4(HCN1):c.209_210insTGGCGGCGG(p.Gly72_Gly74dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000163 in 1,529,784 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00016 ( 0 hom. )
Consequence
HCN1
NM_021072.4 inframe_insertion
NM_021072.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.38
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_021072.4.
BP6
Variant 5-45695884-G-GCCGCCGCCA is Benign according to our data. Variant chr5-45695884-G-GCCGCCGCCA is described in ClinVar as [Likely_benign]. Clinvar id is 412768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000179 (27/150622) while in subpopulation NFE AF= 0.000237 (16/67410). AF 95% confidence interval is 0.000148. There are 0 homozygotes in gnomad4. There are 12 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 27 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HCN1 | NM_021072.4 | c.209_210insTGGCGGCGG | p.Gly72_Gly74dup | inframe_insertion | 1/8 | ENST00000303230.6 | NP_066550.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HCN1 | ENST00000303230.6 | c.209_210insTGGCGGCGG | p.Gly72_Gly74dup | inframe_insertion | 1/8 | 1 | NM_021072.4 | ENSP00000307342 | P2 | |
HCN1 | ENST00000634658.1 | c.209_210insTGGCGGCGG | p.Gly72_Gly74dup | inframe_insertion | 1/2 | 3 | ENSP00000489134 | |||
HCN1 | ENST00000673735.1 | c.209_210insTGGCGGCGG | p.Gly72_Gly74dup | inframe_insertion | 1/9 | ENSP00000501107 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000179 AC: 27AN: 150518Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
27
AN:
150518
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000162 AC: 223AN: 1379162Hom.: 0 Cov.: 33 AF XY: 0.000167 AC XY: 114AN XY: 681952
GnomAD4 exome
AF:
AC:
223
AN:
1379162
Hom.:
Cov.:
33
AF XY:
AC XY:
114
AN XY:
681952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000179 AC: 27AN: 150622Hom.: 0 Cov.: 32 AF XY: 0.000163 AC XY: 12AN XY: 73604
GnomAD4 genome
AF:
AC:
27
AN:
150622
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
73604
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 14, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
not provided Benign:1
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Intellectual disability Benign:1
Likely benign, no assertion criteria provided | clinical testing | Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille | Jan 01, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at